Immune Thrombocytopenia (ITP) Industry Analysis and Forecast 2020-2034: ITP Market Trends, Epidemiology, Treatment Dynamics, Geographic Opportunities, Emerging Therapies, and Access Challenges
02 déc. 2024 04h07 HE
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This...
US Rheumatologists and Dermatologists Report Over Half of their Dermatomyositis Patients Not Optimally Managed, According to Spherix Global Insights
18 oct. 2024 10h56 HE
|
Spherix Global Insights
EXTON, PA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Dermatomyositis (DM) is a rare inflammatory disease characterized by muscle weakness and a distinctive skin rash. Currently, the standard of care...
Intravenous Immunoglobulin Market Size Worth USD 24.76 Billion in 2032 | Emergen Research
17 janv. 2024 10h35 HE
|
Emergen Research
Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the...
Intravenous Immunoglobulin Market 2032 As Expanding Steadily Owing to Rising Demand from Expanding Patient Pool
17 juil. 2023 10h43 HE
|
Acumen Research and Consulting
LOS ANGELES, July 17, 2023 (GLOBE NEWSWIRE) -- The Intravenous Immunoglobulin Market for intravenously administered immunoglobulin (IVIG) formulations has witnessed stable expansion recently,...
Intravenous Immunoglobulin Market Size to Hit USD 29.53 BN by 2032
03 juil. 2023 09h16 HE
|
Precedence Research
Ottawa, July 03, 2023 (GLOBE NEWSWIRE) -- As per Precedence Research, the MEA intravenous immunoglobulin market size was estimated at USD 220.7 million in 2022. Intravenous immunoglobulins are the...
Immunoglobulin Market to exceed USD 20 billion by 2032, Says Graphical Research Powered by GMI
11 juin 2023 20h30 HE
|
Graphical Research
Selbyville, Delaware, June 11, 2023 (GLOBE NEWSWIRE) -- Immunoglobulin Market size is estimated to amass more than USD 20 billion by 2032. The growing adoption of immunoglobulin in therapies...
Intravenous Immunoglobulin Market size to grow by USD 24.4 Billion by 2032, North America to account for 49.5% of the market growth - Market.us
22 mai 2023 08h47 HE
|
Market.Us
New York, May 22, 2023 (GLOBE NEWSWIRE) -- The latest report on the Intravenous Immunoglobulin Market estimates register an incremental growth of USD 24.4 Billion by 2032 from USD 12.6 Billion in...
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
15 mai 2023 21h00 HE
|
Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
Intravenous Immunoglobulin Market Sales to reach US$ 25,884 Million by 2032; Immunodeficiency Disease Treatment to comprise 20% of total Uptake: Persistence Market Research
22 déc. 2022 10h00 HE
|
Persistence Market Research
New York, Dec. 22, 2022 (GLOBE NEWSWIRE) -- As per a study conducted by Persistence Market Research, the global intravenous immunoglobulin market is anticipated to secure US$ 12,000 Million in 2022,...
Global Home Infusion Therapy Market Report 2022: Featuring Option Care Health, Optum, CareCentrix, CVS Health, KabaFusion & More
10 nov. 2022 07h48 HE
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Home Infusion Therapy Market By Indication Analysis, By Product Analysis & By Region-Forecast and Analysis 2022-2028" report has been added...